Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on t...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
IRBIS LLC
2022-01-01
|
| Serie: | Фармакоэкономика |
| Soggetti: | |
| Accesso online: | https://www.pharmacoeconomics.ru/jour/article/view/630 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|